Entry |
|
Gene name |
CREB3L2, BBF2H7
|
Definition |
(RefSeq) cAMP responsive element binding protein 3 like 2
|
KO |
K09048 | cyclic AMP-responsive element-binding protein 3 |
|
Organism |
|
Pathway |
hsa04261 | Adrenergic signaling in cardiomyocytes |
hsa04925 | Aldosterone synthesis and secretion |
hsa04927 | Cortisol synthesis and secretion |
hsa04928 | Parathyroid hormone synthesis, secretion and action |
hsa04935 | Growth hormone synthesis, secretion and action |
hsa04962 | Vasopressin-regulated water reabsorption |
hsa05163 | Human cytomegalovirus infection |
hsa05166 | Human T-cell leukemia virus 1 infection |
|
Network |
nt06123 TNF signaling (viruses and bacteria) nt06124 Chemokine signaling (viruses) nt06161 Human immunodeficiency virus type 1 (HIV-1) nt06162 Hepatitis B virus (HBV) nt06167 Human cytomegalovirus (HCMV) nt06263 Hepatocellular carcinoma nt06310 CRH-ACTH-cortisol signaling nt06316 Angiotensin-aldosterone signaling nt06322 TRH-TSH-TH signaling nt06324 GHRH-GH-IGF signaling nt06360 Cushing syndrome |
Element |
N00297 | ACTH-cortisol signaling pathway |
N00298 | CYP11B1-CYP11B2 fusion to ACTH-cortisol signaling pathway |
N00301 | Angiotensin-aldosterone signaling pathway |
N00302 | Mutation-activated CACNA1D/H to angiotensin-aldosterone signaling pathway |
N00303 | Mutation-activated KCNJ5 to angiotensin-aldosterone signaling pathway |
N00304 | Mutation-inactivated ATP1A1 to angiotensin-aldosterone signaling pathway |
N00305 | Mutation-inactivated ATP2B3 to angiotensin-aldosterone signaling pathway |
N00320 | Mutation-activated PRKACA to ACTH-cortisol signaling pathway |
N00321 | Mutation-activated GNAS to ACTH-cortisol signaling pathway |
N00322 | Mutation-inactivated PRKAR1A to ACTH-cortisol signaling pathway |
N00323 | Mutation-inactivated PDE11A/PDE8B to ACTH-cortisol signaling pathway |
N00324 | CRHR-PKA-ACTH signaling pathway |
N00325 | Mutation-inactivated RASD1 to CRHR-PKA-ACTH signaling pathway |
N00326 | Mutation-activated GNAS to CRHR-PKA-ACTH signaling pathway |
N00327 | Mutation-inactivated PRKAR1A to CRHR-PKA-ACTH signaling pathway |
N00409 | HCMV UL33 to GNB/G-Rho signaling pathway |
N00410 | DRD1-GNAS-AC-PKA signaling pathway |
N00411 | HCMV UL33 to GNAS-AC-PKA signaling pathway |
N00412 | HCMV UL33 to GNAI-AC-PKA signaling pathway |
N00444 | TNF-p38 signaling pathway |
N00544 | HBV HBx to CREB-mediated transcription |
N00782 | TSH-TG signaling pathway |
N00783 | Mutation-inactivated TSH to TSH-TG signaling pathway |
N00784 | Mutation-inactivated TSHR to TSH-TG signaling pathway |
N00797 | Mutation-activated TSHR to TSH-TG signaling pathway |
N00910 | GHRHR-PKA-GH signaling pathway |
N00912 | Mutation-activated GNAS to GHRHR-PKA-GH signaling pathway |
|
Brite |
KEGG Orthology (KO) [BR:hsa00001]
09130 Environmental Information Processing
09132 Signal transduction
04668 TNF signaling pathway
64764 (CREB3L2)
04024 cAMP signaling pathway
64764 (CREB3L2)
04022 cGMP-PKG signaling pathway
64764 (CREB3L2)
04151 PI3K-Akt signaling pathway
64764 (CREB3L2)
04152 AMPK signaling pathway
64764 (CREB3L2)
09150 Organismal Systems
09152 Endocrine system
04911 Insulin secretion
64764 (CREB3L2)
04922 Glucagon signaling pathway
64764 (CREB3L2)
04915 Estrogen signaling pathway
64764 (CREB3L2)
04926 Relaxin signaling pathway
64764 (CREB3L2)
04935 Growth hormone synthesis, secretion and action
64764 (CREB3L2)
04918 Thyroid hormone synthesis
64764 (CREB3L2)
04928 Parathyroid hormone synthesis, secretion and action
64764 (CREB3L2)
04916 Melanogenesis
64764 (CREB3L2)
04925 Aldosterone synthesis and secretion
64764 (CREB3L2)
04927 Cortisol synthesis and secretion
64764 (CREB3L2)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
64764 (CREB3L2)
09155 Excretory system
04962 Vasopressin-regulated water reabsorption
64764 (CREB3L2)
09156 Nervous system
04725 Cholinergic synapse
64764 (CREB3L2)
04728 Dopaminergic synapse
64764 (CREB3L2)
09149 Aging
04211 Longevity regulating pathway
64764 (CREB3L2)
09159 Environmental adaptation
04714 Thermogenesis
64764 (CREB3L2)
09160 Human Diseases
09161 Cancer: overview
05203 Viral carcinogenesis
64764 (CREB3L2)
09162 Cancer: specific types
05215 Prostate cancer
64764 (CREB3L2)
09164 Neurodegenerative disease
05016 Huntington disease
64764 (CREB3L2)
09165 Substance dependence
05030 Cocaine addiction
64764 (CREB3L2)
05031 Amphetamine addiction
64764 (CREB3L2)
05034 Alcoholism
64764 (CREB3L2)
09167 Endocrine and metabolic disease
04931 Insulin resistance
64764 (CREB3L2)
04934 Cushing syndrome
64764 (CREB3L2)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
64764 (CREB3L2)
05161 Hepatitis B
64764 (CREB3L2)
05163 Human cytomegalovirus infection
64764 (CREB3L2)
05165 Human papillomavirus infection
64764 (CREB3L2)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors [BR:hsa03000]
64764 (CREB3L2)
Transcription factors [BR:hsa03000]
Eukaryotic type
Basic leucine zipper (bZIP)
CREB
64764 (CREB3L2)
 |
SSDB |
   |
Motif |
 |
Other DBs |
|
Position |
7q33
|
AA seq |
520 aa  
MEVLESGEQGVLQWDRKLSELSEPGDGEALMYHTHFSELLDEFSQNVLGQLLNDPFLSEK
SVSMEVEPSPTSPAPLIQAEHSYSLCEEPRAQSPFTHITTSDSFNDDEVESEKWYLSTDF
PSTSIKTEPVTDEPPPGLVPSVTLTITAISTPLEKEEPPLEMNTGVDSSCQTIIPKIKLE
PHEVDQFLNFSPKEAPVDHLHLPPTPPSSHGSDSEGSLSPNPRLHPFSLPQTHSPSRAAP
RAPSALSSSPLLTAPHKLQGSGPLVLTEEEKRTLIAEGYPIPTKLPLSKSEEKALKKIRR
KIKNKISAQESRRKKKEYMDSLEKKVESCSTENLELRKKVEVLENTNRTLLQQLQKLQTL
VMGKVSRTCKLAGTQTGTCLMVVVLCFAVAFGSFFQGYGPYPSATKMALPSQHSLQEPYT
ASVVRSRNLLIYEEHSPPEESSSPGSAGELGGWDRGSSLLRVSGLESRPDVDLPHFIISN
ETSLEKSVLLELQQHLVSAKLEGNETLKVVELDRRVNTTF |
NT seq |
1563 nt  +upstreamnt +downstreamnt
atggaggtgctggagagcggggagcagggcgtgctgcagtgggaccgcaagctgagcgag
ctgtcagagcccggggacggcgaggccctcatgtaccacacgcacttctcagaacttctg
gatgagttttcccagaacgtcttgggtcagctcctgaatgatcctttcctctcagagaag
agtgtgtcaatggaggtggaaccttccccgacgtccccggcgcctctcatccaggctgag
cacagctactccctgtgcgaggagcctcgggcccagtcgcccttcacccacattaccacc
agtgacagcttcaatgacgatgaggtggaaagtgagaaatggtacctgtctacagacttc
ccttcaacatccatcaagacagagccagttacagacgaaccacccccaggactcgttccg
tctgtcactctgaccatcacagccatctccaccccgttggaaaaggaggaacctcctctg
gaaatgaacactggggttgattcctcgtgccagaccattattcctaaaattaagctggag
cctcatgaagtggatcagtttctaaacttctctcctaaagaagccccagtggaccacctg
catttgccgcccacccctccgagcagtcacggcagtgactcagagggcagcctgagtccc
aacccacgcctgcaccccttcagcctgcctcagacccacagcccctccagagctgcaccc
cgggccccctccgccctctccagctcccctctcctcacggctcctcataaactgcaggga
tcaggccctctggtcctgacagaggaggagaagaggaccctgatcgctgagggctatccc
atccccaccaaattgcccctgtcaaaatcagaggagaaggccctgaagaaaattcggagg
aagatcaagaataagatttctgctcaggaaagtaggagaaagaagaaagaatacatggac
agcctggagaaaaaagtggagtcttgttcaactgagaacttggagcttcggaagaaggta
gaggttctagagaacactaataggactctccttcagcaactccagaagcttcagactttg
gtgatgggcaaggtttctcgaacctgcaagttagctggcacgcagactggcacctgcctc
atggttgtggtgctgtgctttgccgttgcattcggcagcttctttcaaggctacgggccc
tatccttctgccaccaagatggctctgcccagccagcattccctgcaggagccctacaca
gcctccgtggtgagatccagaaacctgctgatctacgaggaacattctcccccagaggag
tcatccagcccgggctcggctggggagctggggggctgggatagaggttcctccctgctc
agggtgtcagggctggagtccaggccggatgtggatcttccccatttcattatctcgaat
gagaccagcctggagaagtcagtgcttttggagctgcagcagcacctggtcagcgccaaa
ctggaggggaatgaaacactaaaagttgtagaactcgacagaagagtgaacaccactttc
taa |